Remove Cardiology Remove Clinical Trials Remove Pharma Companies
article thumbnail

Tryngolza (Olezarsen) Becomes First FDA-Approved Drug for Familial Chylomicronemia Syndrome

XTalks

XTALKS WEBINAR: Environmental Sustainability and the Supply of Medicines for Clinical Trials Live and On-Demand: Thursday, January 16, 2025, at 10am EST (4pm CET/EU-Central) Register for this free webinar to learn how major pharma companies are working towards environmental sustainability and reducing their environmental impact.

article thumbnail

Content Marketing Campaigns: How Pharma Brands Engage HCPs & Patients

Pharma Marketing Network

So, how can pharma companies use content marketing to engage HCPs and patients effectively ? Pharma brands can develop: Whitepapers on clinical trials showcasing drug effectiveness. Scientific blogs discussing new advancements in oncology, cardiology, or rare diseases. Lets dive in.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Huma’s Kaushik Gune on SaMD and the Company’s Partnership with Bayer

XTalks

We did not get a Class II certification for diabetes only, or orthopedics or cardiology; we got a disease-agnostic certification. Now, as we develop new predictive algorithms, whether that is in diabetes, cardiology, respiratory or oncology, we can bring those algorithms to our platform because it is disease-agnostic.

article thumbnail

Top 10 Heart and Vascular Medications Based on Recent Sales Data

XTalks

The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. Their widespread adoption is driven by strong clinical evidence, broad FDA-approved indications and continued advancements in treatment protocols.

Sales 104
article thumbnail

Combo ‘Polypill’ May Cut Heart Attack, Stroke Risk Up to 40%

The Pharma Data

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. Currently, no such cholesterol/blood pressure polypill exists in the United States, Yusuf said.

Doctors 52
article thumbnail

Audience Engagement Strategies for Pharma Marketing: Boost HCP and Patient Interaction

Pharma Marketing Network

By leveraging digital tools, content personalization, and interactive experiences, pharma companies can enhance engagement and build long-term relationships. This article explores effective audience engagement strategies tailored for pharma marketers, focusing on both HCPs and patients.